Please login to the form below

Not currently logged in
Email:
Password:

Market access

This Market access section features Market access companies, inc health economics; pricing and reimbursement.

Diapharm Ltd.

Diapharm is an international full-service provider for the healthcare industry. We have been a partner for multinationals, SMEs and start-ups for more than 20 years.

ERT, Inc.

ERT is passionate and committed about transforming the way you conduct your drug development and healthcare efforts. Understanding that you need the most accurate, cost-effective and convenient support systems to collect timely, regulatory-compliant data, our team of experts will work together with you to ensure joint success.

Galbraith Wight

The GalbraithWight Business School deliver boths in-house and public training programmes including the only accredited diploma designed specifically to enable managers to lead or contribute effectively to cross functional brand teams at global, regional and local level.

Health Enterprise East Ltd

Health Enterprise East Limited (HEE) is the NHS Innovation Hub for the East of England, and assists with accelerating the development and uptake of innovative MedTech products and services that improve the quality of healthcare delivery.

Insights In Healthcare

We are a fully independent, specialist healthcare company and our core business offers three specific services: Expert Panel and Advisory Board Services, Opinion Leader Identification and Advocacy Development and Strategic Healthcare Consulting.

pharmaLevers GmbH

pharmaLevers GmbH is a Swiss based life science consulting firm in the area of Market Access (Pricing & Reimbursement, Health Economy, HTA and Policy).

PharmaPrice International Ltd

PPi specialises in providing guidance and implementation services for healthcare provision. PPi supports the development of market access strategies as well as the ultimate implementation of such strategies. We accomplish this through our intimate understanding of country healthcare systems and our relationships with payers, physicians, pharmacists and other key stakeholders.

Policy Matters LLP

Founded in 2000, Policy Matters is a healthcare-dedicated, independent, market access consultancy that matches healthcare policy to business to help our clients benefit from the opportunities created by the changing NHS landscape. At Policy Matters we help our clients put market access at the heart of their marketing and market development activities and align the company and brand with customers' needs.

Premark Services Ltd

Consultancy service to the Pharmaceutical Industry on the strategy required to build Stakeholder Value into a product

Prescribing support services

PSS is one of the largest nhs medicines management providers in the UK. We work with a range of partners to deliver practice /ccg wide disease management proggrammes

Roboleo & Co

Roboleo & Co is an independent, UK based consultancy focused on creating innovative, evidenced-based, Market Access solutions

RTI International

RTI is an independent, nonprofit institute that provides research, development, and technical services to government and commercial clients worldwide. Our mission is to improve the human condition by turning knowledge into practice.

SG Market Access Ltd

SG Market Access specialises in Payor NHS Reimbursement Research Integrated care consensus cost impact and steering groups

UK Healthgateway

Selling to the UK National Health Service is challenging and time consuming. UK HealthGateway gives you the solutions and services to win sales.

Verto Health Consulting Ltd.

Consulting to the the health technology industry, we help achieve brand ambitions by optimizing how brands are appraised, positioned and commissioned into the health system.

Visions4health Ltd

Visions4health™ are an established healthcare network agency specialising in market access. We have a proven track record of redefining market access for our clients. Visions4health™

Wickenstones

Mapping market access for success

1 2

Featured jobs

Latest content from PMHub

The patient will see you now
GCI Health’s Laura Starr and Chris Bath report on how the dawning era of mobile tech and the ‘Internet of Things’ has transformed the health and wellness arena. GCI Health
When forecasters take the floor: 6 tips on presenting a forecast
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast Black Swan Analysis
Enablers of drug innovation could lie in the numbers
Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem. Black Swan Analysis
Forecasting for Licensed Compounds
Peter Mansell examines the impact of heavier in-licensing/out-licensing traffic on pharmaceutical forecasting Black Swan Analysis